Lisata Therapeutics Appoints Jeffrey Farrow to Board of Directors
Bitget2026/10/14 20:06- Lisata Therapeutics appointed Jeffrey Farrow to its board, effective October 13, 2026.
- Farrow fills a newly created Class III seat, expanding the board from seven to eight members. He will serve on the Audit Committee.
- He was chief financial officer of Global Blood Therapeutics from 2016 to 2022, through its acquisition by Pfizer.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Strive's bitcoin holdings increased to 35,595, and TD Cowen raised its target price to $56.
New York Federal Reserve Survey: Service Sector Price Increases Hit Fastest Pace Since 2022, Business Activity Index Drops to Lowest Since March
A survey released by the New York Fed on Friday shows that in October, sales prices for service sector firms increased at the fastest pace since 2022, with input costs remaining robust and supply conditions continuing to deteriorate. Businesses’ pessimism about the commercial outlook has significantly intensified, with the overall business activity index falling by 12 points from the previous month to minus 20.7, marking the weakest reading since March.
Raoul Pal Holds Bitcoin, Solana and Ethereum, but Calls One Wildly Undervalued
Ethos Technologies President Wang Lingke Reports Sale of $4.54 Million in Common Shares
Crypto prices
More
